Clinical Trials Browser

Phase 3 × Completed × tocilizumab × Clear all

NCT02046603 2018-12-07

ACT-MOVE

Phase 3 Completed

162 enrolled 30 charts

Arthritis, Rheumatoid

NCT00883753 2014-08-06

An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) Therapy

Phase 3 Completed

934 enrolled 40 charts

Arthritis, Rheumatoid